07.27.2021
Therapeutics
$770,209.00
36 months
Interleukin-4 Activated Macrophages (M(IL4)) for Personalized Cellular Immunotherapy to Treat IBD
This project aims to provide the groundwork for testing a new cell-based therapeutic derived from a patient's own blood cells as a therapeutic option.